| 000 | 01179 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250510205705.0 | ||
| 264 | 0 | _c19940609 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a0304-3835 | ||
| 024 | 7 |
_a10.1016/s0304-3835(77)80032-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmminger, A | |
| 245 | 0 | 0 |
_aA novel class of antitumour agents. II. In vitro testing. _h[electronic resource] |
| 260 |
_bCancer letters _cMar 1977 |
||
| 300 |
_a273-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma 256, Walker _xdrug therapy |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aHeLa Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aPancuronium _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aKahmann, E | |
| 700 | 1 | _aSavage, D S | |
| 773 | 0 |
_tCancer letters _gvol. 2 _gno. 4-5 _gp. 273-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0304-3835(77)80032-3 _zAvailable from publisher's website |
| 999 |
_c44665 _d44665 |
||